What is Minerva Neurosciences Inc (NERV) stock price today?

Minerva Neurosciences Inc (NERV) currently trades at $6.47 per share. The stock has a market capitalization of $281.90M and a P/E ratio of —x.

Is NERV stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Minerva Neurosciences Inc has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

NERV

Minerva Neurosciences Inc

NASDAQ: NERV · HEALTHCARE · BIOTECHNOLOGY

$6.47

+1.25% today

Updated 2026-04-30

Market cap

$281.90M

P/E ratio

—

P/S ratio

1.87x

EPS (TTM)

$-34.67

Dividend yield

—

52W range

$1 – $9

Volume

0.3M

Market cap

$281.90M

P/E ratio

—

P/S ratio

1.87x

EPS (TTM)

$-34.67

Dividend yield

—

52W range

$1 – $9

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$9.50

+46.83%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy0 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-4.48M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-32.11M	$-30.01M	$1.44M	$-293.42M	$-283.67M
EPS	—	—	—	—	$-34.67
Free cash flow	$-24.66M	$-14.78M	$-19.55M	$-13.51B	$-4.48M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-31	KAUL, INDERJIT	Buy	12,169	—
2025-12-22	VAN, HEEK G JAN	Buy	50,000	—
2025-12-22	RACE, GEOFF	Buy	1,500,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NERV	$281.90M	34	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Minerva Neurosciences Inc trades at $6.47. Our Smart Value Score of 34/100 indicates the stock is weak.

Frequently asked questions

What is Minerva Neurosciences Inc's stock price?

Minerva Neurosciences Inc (NERV) trades at $6.47.

Is Minerva Neurosciences Inc overvalued?

Smart Value Score 34/100 (Grade F, Strong Sell).

What is the price target of Minerva Neurosciences Inc (NERV)?

The analyst target price is $9.50, representing +46.8% upside from the current price of $6.47.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.87x

ROE-675.00%

Beta-0.21

50D MA$6.54

200D MA$4.08

Shares out0.04B

Float0.02B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

NERV vs LLY →NERV vs JNJ →NERV vs ABBV →Stock screener →